Healthcare facilities can use this assessment for practitioners who prescribe, dispense, and/or administer opioid products (e.g., fentaNYL, HYDROmorphone, morphine, oxyCODONE).* The assessment addresses selection, dosing, and patient monitoring when using opioid products, and it was developed by the Pennsylvania Patient Safety Authority in collaboration with the Pennsylvania Medical Society. Aggregating and analyzing the results of practitioner assessments can help healthcare facilities identify opportunities for improvement and aid in the development of targeted, high-leverage strategies to improve the safe use of opioids. The target answers are included in this copy of the assessment.
Adapted with permission from the Institute for Safe Medication Practices, Horsham, Pennsylvania
*The analyses upon which this publication is based were in part funded and performed under contract number HHSM-500-2012-00022C, entitled “Hospital Engagement Contractor for Partnership for Patients Initiative.”